AT1 4.17% 2.5¢ atomo diagnostics limited

AT1 chart, page-364

  1. 609 Posts.
    lightbulb Created with Sketch. 533
    As I stated many times before the key problem with this company is volume.
    It states it is building its US exposure with a BDM but it useless having that resource when you can produce volume for such a market.
    This is why Bondi Partners cannot get a deal.
    Elume are producing 30m/month and rising.
    HIV test yes have huge potential in 3rd World counties but they want only a cheap product.
    Atomo cannot make volume hence they get bits and pieces small orders that dont add up to much.
    John talks a big book but cannot deliver.
    The partners so far have been crap.
    Very disappointing management
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
0.001(4.17%)
Mkt cap ! $15.98M
Open High Low Value Volume
2.5¢ 2.5¢ 2.5¢ $9.162K 366.4K

Buyers (Bids)

No. Vol. Price($)
1 192405 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 80000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.